METHOD FOR MAGNETIC RESONANCE IMAGING USING STIMULUS INDUCED ROTARY SATURATION WITH A CONTRAST AGENT

• US 20090123384A1
• Filed: 11/21/2008
• Published: 05/14/2009
• Est. Priority Date: 11/22/2006
• Status: Active Grant

• Current Assignee: Bruce R. Rosen, Lawrence L. Wald, Thomas Witzel
• Original Assignee: Bruce R. Rosen, Lawrence L. Wald, Thomas Witzel
• Inventors: Wald, Lawrence L., Rosen, Bruce R., Witzel, Thomas
• Granted Patent: US 8,849,372 B2
• Time in Patent Office: Days
• US Class Current: 424/9.320
• CPC Class Codes: G01R 33/4806 Functional imaging of brain activation
• CPC Class Codes: G01R 33/5601 involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
• CPC Class Codes: G01R 33/5602 by filtering or weighting based on different relaxation times within the sample, e.g. T1 weighting using an inversion pulse
• CPC Class Codes: G01R 33/5615 Echo train techniques involving acquiring plural, differently encoded, echo signals after one RF excitation, e.g. using gradient refocusing in echo planar imaging [EPI], RF refocusing in rapid acquisition with relaxation enhancement [RARE] or using both RF and gradient refocusing in gradient and spin echo imaging [GRASE]
• CPC Class Codes: G01R 33/5616 using gradient refocusing, e.g. EPI
• CPC Class Codes: G01R 33/5635 Angiography, e.g. contrast-enhanced angiography [CE-MRA] or time-of-flight angiography [TOF-MRA]

Abstract

A method and system for producing an image of a subject with a magnetic resonance imaging (MRI) system, in which the presence of a contrast agent is detected using a spin-lock pulse sequence, is described. More specifically, a contrast agent that induces saturation of magnetic resonance signals responsive to a spin-lock condition is administered to a subject. A spin-lock condition is subsequently established to saturate spins in proximity to the contrast agent. Image data is then acquired with an imaging pulse sequence and images indicative of the presence of the contrast agent are reconstructed.

Claims

1. A method for producing an image of a subject with a magnetic resonance imaging (MRI) system, the steps comprising:

a) administering a contrast agent to the subject;

b) inducing an oscillatory motion of the contrast agent by applying, with the MRI system, a spin-lock radiofrequency (RF) field;

c) acquiring, with the MRI system, image data from magnetic resonance signals that are saturated responsive to the oscillatory motion of the contrast agent; and

d) reconstructing, from the acquired image data, an image indicative of the contrast agent.

2. The method as recited in claim 1 in which step b) includes producing a spin-lock condition in the subject.

3. The method as recited in claim 2 in which step b) further includes:

i) applying a first RF excitation pulse that tips spin magnetization from a longitudinal axis to a transverse plane prior to establishing the spin-lock condition with the spin-lock RF field; and

ii) applying a second RF excitation pulse that tips the spin magnetization from the transverse plane to the longitudinal axis.

4. The method as recited in claim 1 in which the spin-lock RF field is applied for a time period sufficiently long to enable magnetic fields produced by the contrast agent to alter the magnetic resonance signals, the altered magnetic resonance signals providing a contrast mechanism for detecting the contrast agent.

5. The method as recited in claim 1 in which the contrast agent includes a superparamagnetic nanoparticle.

6. The method as recited in claim 5 in which the contrast agent further includes a piezoelectric nanospring.

7. The method as recited in claim 6 in which the superparamagnetic nanoparticle is coupled to the piezoelectric nanospring.

8. The method as recited in claim 6 in which the superparamagnetic nanoparticle is a iron oxide superparamagnetic nanoparticle and the piezoelectric nanospring is a zinc oxide piezoelectric nanospring.

9. The method as recited in claim 1 in which step a) includes at least one of intracranial and intravenous injection of the contrast agent.

10. The method as recited in claim 1 in which step a) includes transferring the contrast agent across the blood-brain barrier.

11. The method as recited in claim 10 in which the contrast agent is transferred across the blood-brain barrier using at least one of a hyperosmolar solution, a vasoactive agent, and an ophthalmic delivery.

12. The method as recited in claim 10 in which the contrast agent is transferred across the blood-brain barrier using at least one of a passive carrier-based transport method and an active receptor-mediated method.